Supplementary Results

Supplementary Figures
Supplementary Figure 1 : µSCALE platform diagram. The µSCALE platform is incorporated around the automated inverted fluorescence microscope and the Triton UV laser system in the Arcturus Veritas Laser Capture Microdissection (LCM) System. The instrument has both bright-field and fluorescence imaging capabilities. The 3-axis stage allows for rapid alignment of the laser with the desired microcapillary. A similar configuration could be recreated with a wide range of automated inverted microscopes with appropriate fluorescence illumination system and laser source. Inset: Sample (brown color imparted by beads) is loaded into the microcapillary array and placed into a holder, which is then analyzed using the instrument. An extraction coverslip is placed below the holder for sample recovery.
Supplementary Figure 3:
Assessment of inter-capillary variability in µSCALE fluorescence measurements. Fluorescent beads (Sphero, FP-4052-2, Spherotech) were analyzed on both µSCALE and a Guava easyCyte flow cytometer (Millipore) (n = 10,000). For µSCALE measurements, the fluorescent beads were loaded into a 20 µm microcapillary array without magnetic particles. Both populations were normalized by the mean of their respective distributions. The coefficients of variation of the bead fluorescence analyzed by flow cytometry and by µSCALE were 0.15 and 0.14, respectively.
Supplementary Figure 4:
Extraction efficiency at different laser powers and bead concentrations. For each extraction, the Triton cutting laser of the LCM was pulsed for approximately 18 msec at a range of different laser powers, ranging from 5-20% of the maximum current as set by the laser manufacturer. Thirty extractions were performed for each condition. Error bars represent the binomial sampling error for each condition.
Supplementary Figure 5:
μSCALE scatter plots from mock library screens. Ratio of Axl wild-type : non-binding clones in each mock library = 1:1 (a), 1:10 (b), 1:100 (c), 1:1,000 (d), 1:10,000 (e), and 1:100,000 (f). Extracted microcapillaries are indicated as red dots (identified as wild-type) and blue dots (identified as non-binding mutant). The total number of analyzed microcapillaries was 74,373, 72,021, 64,931, 87,254, and 276,384, respectively.
Supplementary Figure 6:
Flow cytometry scatter plots showing enrichment of Gas6 binders from the yeast-displayed naïve scFv library following screening by MACS and μSCALE. Yeast cell surface expression levels of scFv proteins are measured by primary and secondary antibodies against the C-terminal c-myc epitope tag (x axis). Gas6 binding is measured using primary and secondary antibodies against a hexahistidine tag (y axis). Normalized emission spectra for ddGFP (green line), ddYFP (yellow), ddOFP (orange dashed line), and ddRFP (red). Reference spectra for ddGFP, ddYFP, and ddRFP taken from previous work. 2
Supplementary Figure 10:
Determination of the pKa of the fluorescent DDAO product used in high-throughput screens of alkaline phosphatase mutants. Error corresponds to a 1-σ (68%) confidence interval for the fit pKa value, and was determined by bootstrapping using case resampling of the data. Subsequent enzymatic assays were performed at pH 8.0 (3 units above the product pKa). (a) Emission spectra for the DDAO product were measured as a function of product concentration on a Biotek Synergy H4 plate reader spectrophotometer, and the peak emissions were quantified to yield the calibration line on the right. The same fluorescence acquisition parameters (sensitivity = 100 and bandwidth = 9.0 nm) for the spectrophotometer were used for all bulk enzymatic assays. (b) A similar calibration line was generated on the μSCALE platform by loading product standards of variable concentration onto isolated spots on a single microcapillary array and then measuring the fluorescence intensity of each microcapillary on the array (n ≈ 3500 microcapillaries for each concentration). Error bars reflect the standard deviation across all microcapillaries in each spot and were used to fit a calibration line using weighted least squares.
Supplementary Figure 12:
Calibration curve for quantifying levels of inorganic phosphate present in alkaline phosphatase reactions using fluorescently labeled phosphate-binding protein from E. coli. Error bars reflect the standard deviation over three measurements. A fit to a two-state binding isotherm is overlaid above the data as a solid line. . Active site zinc ions are shown as gray spheres, D101 and R166 residues are rendered as sticks, and all other protein residues are depicted in ribbon representation. The D101 position is known to be important for positioning the R166 residue that coordinates the phosphate ion within the alkaline phosphatase active site. As such, the D101G mutation uncovered in our screens likely alters the positioning of R166 in a manner that lowers the affinity of the enzyme for inorganic phosphate.
Supplementary Figure 16:
Kinetics of yeast-displayed WT alkaline phosphatase and the three variants isolated from μSCALE screens as a function of DDAOP concentration. Fits to the standard Michaelis-Menten model are overlaid above the data as solid lines. All reactions were performed at a cell loading of 3200 cells/μl (equivalent to the catalyst concentration within a single 20 μm microcapillary), so the resulting kinetic parameters can be interpreted as per-cell specific activities. Error bars correspond to the standard deviation of three technical replicates.
Supplementary Figure 17:
Expression profiles of alkaline phosphatase mutants displayed on the surface of yeast (n = 10,000 cells for each sample). Protein display levels were measured via antibody labeling of the C-terminal c-myc epitope tag fused to each enzyme and quantified using flow cytometry.
Supplementary Figure 18: Effect of magnetic beads on µSCALE fluorescence measurements.
Fluorescent beads (Sphero, FP-4052-2, Spherotech) were analyzed on µSCALE with and without the presence of the magnetic particles used for extraction (n = 10,000). a) Histograms of the two conditions. The mean of the normalized "with beads" population is 0.83, demonstrating that the magnetic beads partially occlude the fluorescence intensity of the microcapillaries. The coefficients of variation of the fluorescent bead distributions with and without magnetic particles are 0.2 and 0.14, respectively, demonstrating that the use of magnetic beads for extraction does not significantly increase the variability of fluorescence measurements on µSCALE. b) Fluorescence and bright-field images of the two conditions. The presence of magnetic beads reduces the fluorescence intensity and obscures the bright-field images.
Supplementary Tables
Initial Summary of spectral properties of ddOFP and its constituent monomers, A copy and B copy (ddFP technology is described in Supplementary Figure  7) . EC, extinction coefficient (M -1 cm -1 ); QY, quantum yield; NA, not applicable. QY determined relative to mCitrine (QY = 0.78). Brightness is the product of extinction coefficient and quantum yield. The B copy is non-fluorescent. A genetic fusion of A and B copies (tandem dimer OFP [tdOFP]) was used to determine spectral properties of the ddOFP system. Table 5 : Relative rates of WT alkaline phosphatase and the three variants isolated from μSCALE screens in both yeast-displayed and purified enzyme formats. All reactions were conducted using 1 μM DDAOP in the presence of 15 μM added inorganic phosphate. All yeast assays were carried out at a cell density of 3200 cells/μl using freshly transformed cells. Purified enzyme reactions with WT alkaline phosphatase and the D101G mutant were carried out using 50 pM enzyme, while reactions with the I16V-N145I-D294G and N197S-T148P-S175R triple mutants were carried out using 50 nM enzyme (with rates scaled accordingly). Relative rates are defined on a per-cell basis for yeast-displayed constructs and on a per-mole basis for purified constructs, and are normalized to the WT values. Uncertainties in reported rates reflect the standard deviation from three technical replicates. Relative yeast surface expression levels of each mutant are shown alongside the rate data for comparison, demonstrating that improved performance of the I16V-N145I-D294G and N197S-T148P-S175R triple mutants in cell-based assays can be partially attributed to increased expression of these variants. Relative expression is calculated as (<mutant> -<uninduced>)/(<WT> -<uninduced>), where <> refers to the geometric mean of the data in Supplementary Figure 17 . Table 6 : Metal ion and phosphorous content in WT alkaline phosphatase and the two triple mutants isolated from μSCALE screens, as measured by atomic emission spectroscopy (AES). The expected Zn/Mg/protein stoichiometry for an alkaline phosphatase monomer is 2:1:1. 3 In addition, WT alkaline phosphatase expresses with inorganic phosphate bound in the active site in a 1:1 stoichiometry.
Mutant
Deviations from these values in the WT alkaline phosphatase sample presumably reflect errors in sample preparation and determination of protein concentration. The lack of significant metal occupancy in the active sites of the I16V-N145I-D294G and N197S-T148P-S175R triple mutants helps explain the poor activity of these variants. The AES data, along with the crystal structure of WT alkaline phosphatase (PDB 1ALK), support a model in which mutations at N145 and T148 disrupt the folding of the soluble protein and hence its ability to bind the metal cofactors required for efficient catalysis. 
